Analogous to virus experiments, blocking PD-1/PD-L1 interactions can result in the reinvigoration of efficient anti-cancer immune responses, both in mouse models and in patients, proving that T cell exhaustion significantly contributes to immunological tolerance towards tumor cells [37,38,39]. Here, PDCD1 is linked to cancer.